Cargando…

The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma

BACKGROUND: Gliomas, the most prevalent primary malignant tumors of the central nervous system in adults, exhibit slow growth in lower-grade gliomas (LGG). However, the majority of LGG cases progress to high-grade gliomas, posing challenges for prognostication. The tumor microenvironment (TME), char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xu, Yan, Zihan, Fan, Kaiyu, Guan, Xueyi, Hu, Bohan, Li, Xiang, Ou, Yunwei, Cui, Bing, An, Lingxuan, Zhang, Yaohua, Gong, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470026/ https://www.ncbi.nlm.nih.gov/pubmed/37662954 http://dx.doi.org/10.3389/fimmu.2023.1220100

Ejemplares similares

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
por: Ait Ssi, Saadia, et al.
Publicado: (2021)

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma
por: Xie, Qin, et al.
Publicado: (2023)

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
por: Wang, Weichen, et al.
Publicado: (2022)

Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas
por: Li, Junhong, et al.
Publicado: (2023)

Immune landscape and prognostic gene signatures in gastric cancer: implications for cachexia and clinical outcomes
por: Sui, Xiangyu, et al.
Publicado: (2023)

Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
por: Jiang, Hongxiang, et al.
Publicado: (2022)

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
por: Lei, Qiang, et al.
Publicado: (2023)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma
por: Wan, Sicheng, et al.
Publicado: (2022)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
por: Zhang, Nan, et al.
Publicado: (2021)

Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Computational analysis of the mesenchymal signature landscape in gliomas
por: Celiku, Orieta, et al.
Publicado: (2017)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma
por: Zeng, Wen-Jing, et al.
Publicado: (2022)

Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma
por: Xiao, Junbo, et al.
Publicado: (2022)

Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas
por: Zhao, Wei-jiang, et al.
Publicado: (2021)

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures
por: Wang, Tao, et al.
Publicado: (2022)

Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages
por: Liu, Yuyang, et al.
Publicado: (2022)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
por: Zhi, Wenqian, et al.
Publicado: (2023)

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023)

Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease
por: Bai, Xiaowu, et al.
Publicado: (2022)

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures
por: Wang, Tao, et al.
Publicado: (2023)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
por: Tong, Shiao, et al.
Publicado: (2022)

A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response
por: Yang, Jiaxing, et al.
Publicado: (2022)

M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma
por: Qu, Xiaodong, et al.
Publicado: (2022)

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023)

A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer
por: Zheng, Ming, et al.
Publicado: (2022)

Prognostic Implications of the Complement Protein C1q in Gliomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
por: Chen, Mu, et al.
Publicado: (2022)

Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma
por: Ma, Xiaochen, et al.
Publicado: (2022)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma
por: Zhang, Ze, et al.
Publicado: (2023)

Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
por: Jiang, Feng, et al.
Publicado: (2022)

Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients
por: Del Bianco, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s434sp2tfp2bf2u1hrt90tdvf7